Skip to main content
. 2019 Jul 25;11:7031–7038. doi: 10.2147/CMAR.S197560

Table 1.

Clinicopathologic findings of patients with multiple GISTs

Case Age/sex Tumor Site/size (cm)/MF Histotype Risk category Other diseases Mutation status Follow-up
Outcome Months
1 37/F 1a
1b
Stomach/9/>5
Stomach/4/>5
S
S
HR
IR
Pulmonary chondromas WT
WT
NED 113
2 39/F 2a
2b
2c
Stomach /11/>5
Stomach/3.5/>5
Small intestine/too small/>5
M
M
M
HR
IR
IR
Adrenal adenoma
Pulmonary chondromas
WT
WT
NA
NED 111
3 46/F 3a
3b
Duodenum/2.0/<5
Stomach/0.5/<5
S
S
VLR
VLR
Absent NA
NA
NED 122
4 51/M 4a
4b
Stomach/4.0/<5
Stomach/1.0/<5
S
S
LR
VLR
Absent KIT exon11: c.1728_1739dup
NA
NED 57
5 51/F 5a
5b
Small intestine/4.5/>10
Small intestine/0.5/>10
S
S
HR
HR
Breast cancer WT
WT
NED 183
6 52/M 6a
6b
6c
Small intestine/13/>5
Small intestine/4/>5
Small intestine/2/>5
S
S
S
HR
HR
IR
Absent KIT exon11:c.1655_1666del
WT
NA
AWD 62
7 55/F 7a Stomach/6.0/<5 S IR Neurofibromas WT NED 37
7b Small intestine/2/<5 S VLR NA
7c Small intestine/1/<5 S VLR NA
7d Small intestine/1/<5 S VLR NA
7e Small intestine/0.5/<5 S VLR NA
7f Small intestine/0.5/<5 S VLR NA
8 57/M 8a
8b
8c
Mesentery/17/>5
Mesentery/11/>5
Mesentery/2/>5
S
S
S
HR
HR
IR
Absent KIT exon11: p.M552_Q556del
NA
NA
DOD 40
9 58/F 9a
9b
Stomach/2/<5
Stomach/0.9/<5
S
S
LR
VLR
Breast cancer KIT exon11: Q556-E561 Del
KIT exon11:Ins QPS+V560E
NED 3
10 59/F 10a
10b
10c
Rectum/3/>5
Rectum/1/>5
Rectum/too small/>5
S
S
S
HR
IR
IR
Absent PDGFRA exon12: p.P567P
WT
WT
NED 158
11 64/F 11a
11b
11c
11d
11e
11f
Small intestine/6/<5
Small intestine/4.5/<5
Small intestine/2/<5
Small intestine/2/<5
Small intestine/2/<5
Small intestine/1.8/<5
S
S
S
S
S
S
HR
LR
VLR
VLR
VLR
VLR
Neurofibromas PDGFRA exon18:p.V824V
PDGFRA exon18:p.V824V
PDGFRA exon18:p.V824V
PDGFRA exon18:p.V824V
PDGFRA exon18:p.V824V
NA
NED 125
12 66/M 12a
12b
Stomach/3/<5
Stomach/0.4/<5
S
S
LR
VLR
Absent WT
NA
NED 65
13 68/M 13a
13b
13c
Small intestine/9/<5
Small intestine/3.8/<5
Small intestine/1.9/<5
S
S
S
HR
LR
VLR
Absent NA
NA
NA
DOPC /
14 69/M 14a
14b
Stomach/2.9/<5
Stomach/1.5/<5
S
S
LR
VLR
Absent PDGFRA exon 18 : p.V824V
KIT exon11: p.Y578_D579dup
DUNC 47
15 72/M 15a
15b
Stomach/5/<5
Stomach/1/<5
M
M
LR
VLR
Absent PDGFRA exon 12: p.P567P
NA
DOD 24
16 73/F 16a
16b
Stomach/3.5/>10
Stomach/2.5/>10
M
M
HR
HR
Absent KIT exon11: p.T574_R588dup
PDGFRA exon18: p.D842V
DUNC 52
17 74/F 17a
17b
Stomach/1.6/<5
Stomach/0.3/<5
S
S
LR
VLR
Absent NA
NA
NED 100
18 76/F 18a
18b
18c
Stomach/8/>5
Stomach/2/>5
Stomach/too small/>5
S
S
S
HR
IR
IR
Absent KIT exon11: p.V559_T574del
WT
WT
NED 142
19 79/M 19a Small intestine/6.5/>5 S HR Absent KIT exon11: p.Y570_L576del DOD 118
19b Small intestine/1.2/>5 S IR KIT exon11: p.Y570_L576del
20 80/M 20a
20b
Stomach/3.5/<5
Stomach/1.5/<5
E
S
IR
VLR
Absent KIT exon11: p.W557R
PDGFRA exon18: p.D842V
NED 66

Abbreviations: AWD, alive with disease; NED, no evidence of disease; DOD, dead of disease; DOPC, dead of postoperative complications; DUNC, dead of unknown causes; E, epithelioid; S, spindle; MF, mitotic figures, (50/HPF); VLR, very low risk; LR, low risk; IR, intermediate risk; HR, high risk; WT, wild-type; NA, not available.